Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 49

Sort by

Sort Order Select

Journal Articles

Largest Real-World Evaluation of Treatment Regimens and Clinical Outcomes Among Patients with Acute Promyelocytic Leukemia in the US: Data from the Command Consortium

Blood (2024) 144 (Supplement 1): 5174.

https://doi.org/10.1182/blood-2024-198914

Published: 2024

Journal Articles

Next-Generation Sequencing-Based T-Cell Receptor (TR) Measurable Residual Disease Monitoring Does Not Predict Relapse in T-Lineage Acute Lymphoblastic Leukemia

Rafael Madero-Marroquin, Adnan Askari, Yenny Vanegas Moreno, Clare E Anderson, Talha Badar, Guru Subramanian Guru Murthy, Chenyu Lin, Alexander Coltoff, Adam S. Duvall, Richard A. Larson, Olatoyosi Odenike, Wendy Stock, Anand Ashwin Patel, Caner Saygin

Blood (2024) 144 (Supplement 1): 5937.

https://doi.org/10.1182/blood-2024-203665

Published: 2024

Journal Articles

Impact of Social Determinants of Health and Novel Therapies on the Outcomes of Relapsed and Refractory Diffuse Large B Cell Lymphoma

Chenyu Lin, Micaela R Scobie, Clare E Anderson, Daphne R Friedman, Michael J Kelley, Thomas D Rodgers

Blood (2023) 142 (Supplement 1): 2396.

https://doi.org/10.1182/blood-2023-178803

Published: 2023

Journal Articles

Tolerability and Outcomes of Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia in Patients with Severe Renal Dysfunction

Chenyu Lin, Clare E Anderson, Micaela R Scobie, Thomas D Rodgers, Michael J Kelley, Daphne R Friedman

Blood (2023) 142 (Supplement 1): 4648.

https://doi.org/10.1182/blood-2023-178142

Published: 2023

Journal Articles

Clinical Experience with Afamelanotide for the Protoporphyrias in the United States

Rebecca Karp Leaf, Sarina Elmariah, Paul Yanning Jiang, Jennifer Mead, Pamela Hodges, Sarah Elizabeth Valiante, Francesca Mernick, Karl E Anderson, Amy Dickey

Blood (2022) 140 (Supplement 1): 2201–2202.

https://doi.org/10.1182/blood-2022-163566

Published: 2022

Journal Articles

Erythropoietic Protoporphyria: Phase 2 Clinical Trial Results Evaluating the Safety and Effectiveness of Dersimelagon (MT-7117), an Oral MC1R Agonist

Manisha Balwani, Herbert L. Bonkovsky, MD, Kirstine J Belongie, PhD, Karl E Anderson, MD, Fumihiro Takahashi, PhD, Antonio Irizarry, MBA, Mark Amster, MD, D. Montgomery Bissell, MD, Bruce Wang, MD, Lydie Hazan, MD, Charles J. Parker, MD, Edward Cordasco, MD, Cynthia Levy, MD, Robert J. Desnick, MD PhD

Blood (2020) 136 (Supplement 1): 51.

https://doi.org/10.1182/blood-2020-142467

Published: 2020

Journal Articles

2 nd cycle Remission Achievement with 7+3 Is Associated with Shorter Survival in Adults with Newly Diagnosed Acute Myeloid Leukemia: Analysis of Recent SWOG Trials

Megan Othus, PhD, Elihu H. Estey, MD, Guillermo Garcia-Manero, MD, Brent Wood, MD PhD, Derek Stirewalt, MD, John Godwin, MD, James K. Weick, MD, Jeanne E. Anderson, MD, Frederick R. Appelbaum, MD, Harry P. Erba, MD PhD, Roland B. Walter, MD PhD MS

Blood (2018) 132 (Supplement 1): 3978.

https://doi.org/10.1182/blood-2018-99-117525

Published: 2018

Journal Articles

Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival ("Potential Cure") over the Past Four Decades: Analysis of SWOG Trial Data

Megan Othus, PhD, Guillermo Garcia-Manero, MD, John Godwin, MD, James K. Weick, MD, Jeanne E. Anderson, MD, Derek Stirewalt, MD, Frederick R. Appelbaum, MD, Harry P. Erba, MD PhD, Elihu H. Estey, MD

Blood (2017) 130 (Supplement 1): 1301.

https://doi.org/10.1182/blood.V130.Suppl_1.1301.1301

Published: 2017

Journal Articles

AcDVP16 Induction Therapy for Acute Myeloid Leukemia

Michael Richard Grunwald, MD, Amy M. Ellenburg, PharmD, Michael Keith Allister Zimmerman, MS, Jing Ai, MD PhD, Thomas G. Knight, MD, Lauren M. Bohannon, Danielle Boselli, MS, Jigar Trivedi, MSc, PharmD, Margaret A. Croom, PharmD, William E. Anderson, JD, MS, James T Symanowski, PhD, Edward A Copelan, MD, Dragos Plesca, PharmD, Jonathan M. Gerber, MD

Blood (2017) 130 (Supplement 1): 3902.

https://doi.org/10.1182/blood.V130.Suppl_1.3902.3902

Published: 2017

Journal Articles

Prediction Of CR On Reinduction In Patients With Newly Diagnosed Acute Myeloid Leukemia Given Intensive Induction Regimens: A Report From SWOG and Cleveland Clinic

Megan Othus, PhD, Mukherjee Sudipto, MD, Mikkael A. Sekeres, MD, MS, John Godwin, MD, Jeanne E. Anderson, MD, Stephen Petersdorf, MD, Frederick R. Appelbaum, MD, Harry P Erba, MD, Elihu H. Estey, MD

Blood (2013) 122 (21): 3924.

https://doi.org/10.1182/blood.V122.21.3924.3924

Published: 2013

Journal Articles

Impact Of Cytarabine Dose In The Induction Regimen On The Outcome Of Patients With Newly Diagnosed Acute Myeloid Leukemia With Or Without NPM1 and/Or FLT3 Mutations: A SWOG and MD Anderson Cancer Center Report

Farhad Ravandi, MD, Megan Othus, PhD, Stefan H. Faderl, MD, Derek L. Stirewalt, MD, Sherry R. Pierce, RN, BS, Gautam Borthakur, MD, John Godwin, MD, Jeanne E. Anderson, MD, Stephen Petersdorf, MD, Jorge E. Cortes, MD, Fabiana Ostronoff, MD, Era Pogosova-Agadijanyan, MD, Frederick R. Appelbaum, MD, Hagop M. Kantarjian, MD, Elihu H. Estey, MD

Blood (2013) 122 (21): 2686.

https://doi.org/10.1182/blood.V122.21.2686.2686

Published: 2013

Journal Articles

A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells

Kathryn W. Juchem, Britt E. Anderson, Cuiling Zhang, Jennifer M. McNiff, Anthony J. Demetris, Donna L. Farber, Andrew J. Caton, Warren D. Shlomchik, Mark J. Shlomchik

Blood (2011) 118 (23): 6209–6219.

https://doi.org/10.1182/blood-2011-01-330035

Published: 2011

Includes: Supplemental data

Journal Articles

KIT Mutations Are Rare Among Elderly AML Patients: A SWOG Report

Fabiana Ostronoff, MD, Megan Othus, PhD, Phoenix A. Ho, MD, Stephen H. Petersdorf, MD, Jeanne E. Anderson, MD, John E. Godwin, MD, MS, Cheryl L Willman, MD, Jerald P. Radich, MD, Frederick R. Appelbaum, MD, Derek L. Stirewalt, MD, Soheil Meshinchi, MD, PhD

Blood (2011) 118 (21): 2510.

https://doi.org/10.1182/blood.V118.21.2510.2510

Published: 2011

Journal Articles

Prevalence and Clinical Implications of IDH2 R140 and R172 Mutations in Older Adults with AML: A Report From SWOG,

Phoenix A. Ho, MD, Megan Othus, PhD, Fabiana Ostronoff, MD, Stephen H. Petersdorf, MD, Jeanne E. Anderson, MD, John E. Godwin, MD, MS, Cheryl L Willman, MD, Jerald P. Radich, MD, Frederick R. Appelbaum, MD, Derek L. Stirewalt, MD, Soheil Meshinchi, MD, PhD

Blood (2011) 118 (21): 3516.

https://doi.org/10.1182/blood.V118.21.3516.3516

Published: 2011

Journal Articles

DNMT3A Mutations Independently Predict Poor Outcome in Older AML Patients: A SWOG Report,

Blood (2011) 118 (21): 3519.

https://doi.org/10.1182/blood.V118.21.3519.3519

Published: 2011

Journal Articles

Prognostic Import of French-American-British (FAB) System As Embedded in 2008 Revision of World Health Organization Classification of AML: Review of SWOG Data

Laura F Newell, MD, Megan Othus, PhD, Roland B. Walter, MD, PhD, Stephen H. Petersdorf, MD, Thomas Chauncey, MD, PhD, Jeanne E. Anderson, MD, John E. Godwin, MD, MS, Kenneth J. Kopecky, PhD, Frederick R. Appelbaum, MD, Elihu H. Estey, MD

Blood (2011) 118 (21): 1446.

https://doi.org/10.1182/blood.V118.21.1446.1446

Published: 2011

Journal Articles

Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG

Blood (2011) 118 (17): 4561–4566.

https://doi.org/10.1182/blood-2011-04-348888

Published: 2011

Includes: Supplemental data

Journal Articles

The GTPase-activating protein ARAP3 regulates chemotaxis and adhesion-dependent processes in neutrophils

Laure Gambardella, Karen E. Anderson, Claudia Nussbaum, Anne Segonds-Pichon, Tânia Margarido, Laura Norton, Thomas Ludwig, Markus Sperandio, Phillip T. Hawkins, Len Stephens, Sonja Vermeren

Blood (2011) 118 (4): 1087–1098.

https://doi.org/10.1182/blood-2010-10-312959

Published: 2011

Includes: Multimedia, Supplemental data

Journal Articles

Phosphorylation of threonine 154 in p40 phox is an important physiological signal for activation of the neutrophil NADPH oxidase

Tamara A. M. Chessa, Karen E. Anderson, Yanhua Hu, Qingbo Xu, Oliver Rausch, Len R. Stephens, Phillip T. Hawkins

Blood (2010) 116 (26): 6027–6036.

https://doi.org/10.1182/blood-2010-08-300889

Published: 2010

Includes: Supplemental data

Journal Articles

Low-strength T-cell activation promotes Th17 responses

Harriet A. Purvis, Jeroen N. Stoop, Jelena Mann, Steven Woods, Anne E. Kozijn, Sophie Hambleton, John H. Robinson, John D. Isaacs, Amy E. Anderson, Catharien M. U. Hilkens

Blood (2010) 116 (23): 4829–4837.

https://doi.org/10.1182/blood-2010-03-272153

Published: 2010

Includes: Supplemental data

NARROW

Largest Real-World Evaluation of Treatment Regimens and Clinical Outcomes Among Patients with Acute Promyelocytic Leukemia in the US: Data from the Command Consortium

Next-Generation Sequencing-Based T-Cell Receptor (TR) Measurable Residual Disease Monitoring Does Not Predict Relapse in T-Lineage Acute Lymphoblastic Leukemia

Impact of Social Determinants of Health and Novel Therapies on the Outcomes of Relapsed and Refractory Diffuse Large B Cell Lymphoma

Tolerability and Outcomes of Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia in Patients with Severe Renal Dysfunction

Clinical Experience with Afamelanotide for the Protoporphyrias in the United States

Erythropoietic Protoporphyria: Phase 2 Clinical Trial Results Evaluating the Safety and Effectiveness of Dersimelagon (MT-7117), an Oral MC1R Agonist

2 nd cycle Remission Achievement with 7+3 Is Associated with Shorter Survival in Adults with Newly Diagnosed Acute Myeloid Leukemia: Analysis of Recent SWOG Trials

Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival ("Potential Cure") over the Past Four Decades: Analysis of SWOG Trial Data

AcDVP16 Induction Therapy for Acute Myeloid Leukemia

Prediction Of CR On Reinduction In Patients With Newly Diagnosed Acute Myeloid Leukemia Given Intensive Induction Regimens: A Report From SWOG and Cleveland Clinic

Impact Of Cytarabine Dose In The Induction Regimen On The Outcome Of Patients With Newly Diagnosed Acute Myeloid Leukemia With Or Without NPM1 and/Or FLT3 Mutations: A SWOG and MD Anderson Cancer Center Report

A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells

KIT Mutations Are Rare Among Elderly AML Patients: A SWOG Report

Prevalence and Clinical Implications of IDH2 R140 and R172 Mutations in Older Adults with AML: A Report From SWOG,

DNMT3A Mutations Independently Predict Poor Outcome in Older AML Patients: A SWOG Report,

Prognostic Import of French-American-British (FAB) System As Embedded in 2008 Revision of World Health Organization Classification of AML: Review of SWOG Data

Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG

The GTPase-activating protein ARAP3 regulates chemotaxis and adhesion-dependent processes in neutrophils

Phosphorylation of threonine 154 in p40 phox is an important physiological signal for activation of the neutrophil NADPH oxidase

Low-strength T-cell activation promotes Th17 responses

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only